/CORZ
Core Scientific, Inc.
CORZ • NASDAQCORZ • NASDAQ • Technology
$16.23+6.08%+0.93
$16.23+6.08%(+0.93)Technology
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
0High Risk
Momentum
44Neutral
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
11.9%▼11.8pp
Revenue after COGS
Operating
-45.4%▼41.6pp
After operating expenses
Net
-90.5%▲167.0pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
-16.0
Price vs earnings
EV/EBITDA
-71.0
Enterprise value
FCF Yield
-9.7%
Cash generation
Earnings Yield
-6.2%
Inverse of P/E
Capital Efficiency
2
GoAI Quality ScoreWeak
⚠High Leverage Risk
Large ROE-ROA gap with weak interest coverage suggests the high returns are fueled by excessive debt rather than operational efficiency.
ROEReturn on Equity
30.0%Strong
ROAReturn on Assets
-12.3%Weak
ROICReturn on Invested Capital
-9.2%Weak
Financial Health
Current RatioAdequate
1.15
Short-term solvency (>1.5)
Net Debt / EBITDANet Cash
-9.88x
Debt repayment capacity (<3x)
Income QualityWeak
-0.96
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $319.02M | $510.67M | $502.40M | $640.31M | $544.48M |
| Gross Profit | $37.90M | $121.07M | $123.46M | $8.40M | $238.86M |
| Gross Margin | 11.9% | 23.7% | 24.6% | 1.3% | 43.9% |
| Operating Income | -$144.70M | -$19.20M | $8.96M | -$2.11B | $166.64M |
| Net Income | -$288.62M | -$1.32B | -$246.49M | -$2.15B | $47.31M |
| Net Margin | -90.5% | -257.5% | -49.1% | -335.2% | 8.7% |
| EPS | -$0.88 | -$5.14 | -$0.65 | -$6.30 | $0.23 |
Average Price Target
$26.20▲ 61.4% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Core Scientific, Inc., the average price target is $26.20, with a high forecast of $40.00 and a low forecast of $20.00. The average price target represents a 61.4% increase from the current price of $16.23.
Highest
$40.00
Average
$26.20
Lowest
$20.00
Rating Distribution
Strong Buy
0
0%
Buy
19
86%
Hold
3
14%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Canaccord Genuity● Maintain
Buy
2026-03-04Macquarie● Maintain
Outperform
2026-03-04Cantor Fitzgerald● Maintain
Overweight
2026-03-03Needham▲ Upgrade
Hold→Buy
2026-03-03HC Wainwright & Co.● Maintain
Buy
2026-03-03Ladenburg Thalmann● Maintain
Buy
2026-03-03Keefe, Bruyette & Woods● Maintain
Outperform
2026-01-27BTIG▲ Upgrade
Neutral→Buy
2026-01-06Citizens▲ Upgrade
Market Perform→Market Outperform
2025-12-18Bernstein● Maintain
Outperform
2025-11-03Earnings History & Surprises
BEAT RATE
46%
Last 13 quarters
AVG SURPRISE
-770.9%
EPS vs Estimate
BEATS / MISSES
6/7
Last 13 quarters
LATEST EPS
$-0.29
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
-7.4%
$-0.29 vs $-0.27
Q4 '25
-558.9%
$-0.46 vs $-0.07
Q3 '25
+42.9%
$-0.04 vs $-0.07
Q2 '25
+16.7%
$-0.10 vs $-0.12
Q1 '25
+90.0%
$-0.01 vs $-0.10
Q4 '24
-18.2%
$-0.13 vs $-0.11
Q3 '24
+20.0%
$-0.04 vs $-0.05
Q2 '24
+280.0%
$0.19 vs $0.05
Q1 '24
-566.7%
$-0.20 vs $-0.03
Q4 '23
No data
Q3 '23
No data
Q2 '23
No data
No investor questions available.
Latest News
No news available